Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H26N2S.ClH |
| Molecular Weight | 362.96 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCC1=CC=C2SC3=CC=CC=C3N(CC(C)CN(C)C)C2=C1
InChI
InChIKey=ZVSKDFRXWJPINY-UHFFFAOYSA-N
InChI=1S/C20H26N2S.ClH/c1-5-16-10-11-20-18(12-16)22(14-15(2)13-21(3)4)17-8-6-7-9-19(17)23-20;/h6-12,15H,5,13-14H2,1-4H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [DEMENTIA PRAECOX. CURE BY RP-6484]. | 1963-12 |
|
| [On the clinical use in neuropsychiatry of 3-ethyl-10-(2-methyl-3-dimethylaminopropyl)-phenothiazine HCl (RP-6484), new phenothiazine neuroleptic]. | 1962-06-02 |
|
| [Clinical study of a new phenothiazine derivative, RP-6484]. | 1960-06-11 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5668177
Pigs: Ethyl isobutrazine (Etymemazine) and pethidine were each administered
at a dose rate of 5 mg/kg
Route of Administration:
Intramuscular
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
169471
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
CHEMBL2008544
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
71822
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
m728
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | Merck Index | ||
|
3737-33-5
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
DTXSID1045110
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
A7002E7T2Z
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
DBSALT001681
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
C81141
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY | |||
|
223-111-8
Created by
admin on Mon Mar 31 18:19:20 GMT 2025 , Edited by admin on Mon Mar 31 18:19:20 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD